U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Tuesday.

Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) fell sharply in today's pre-market trading as the company announced its collaboration and license agreement with Pfizer on giroctocogene fitelparvovec will terminate effective April 21, 2025.

Sangamo Therapeutics shares dipped 50% to $1.17 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• Design Therapeutics, Inc. (NASDAQ:DSGN) dipped 13.8% to $5.32 in pre-market trading.
• Richtech Robotics Inc. (NASDAQ:RR) fell 12.3% to $3.06 in pre-market trading after surging over 20% on Monday.
• Arko Corp. (NASDAQ:ARKO) fell 10% to $6.01 in pre-market trading.
• Dave Inc. (NASDAQ:DAVE) fell 8.4% to $86.56 in pre-market trading. Dave issued a statement in response to amended FTC complaint and issued an update on new Extracash fee structure.
• Senseonics Holdings, Inc. (NYSE:SENS) declined 8.2% to $0.5050 in pre-market trading following a 7% drop on Monday.
• SEALSQ Corp (NASDAQ:LAES) fell 5% to $8.14 in pre-market trading after declining around 6% on Monday.
• Stevanato Group S.p.A. (NYSE:STVN) fell 2.6% to $20.99 in pre-market trading.

Now Read This:

• Top 3 Tech Stocks That May Fall Off A Cliff This Quarter